Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH Antagonist Priming for Follicular Synchronization
NCT05071339Phase 4Unknown
- Sponsor
- Shamir Medical Center
- Start
- Apr 2021
- Primary completion
- Mar 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ganirelix and cetrorelix in infertility, sponsored by Shamir Medical Center. Primary endpoint: Synchronization of follicles at 2 years. Status: unknown.
02
Drugs
ganirelixcetrorelix
03
Conditions
infertility
Beyond the preview
Go deeper on NCT05071339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05071339.